Skip to main content

Oligonucleotide Biologist

Organization

Deep Genomics

Job Location

661 University Avenue
Toronto ON M5G1M1
Canada

Benefits

  • A highly competitive salary, health and dental benefits, and meaningful equity compensation.
  • Exceptional opportunities for learning and growth.
  • A collegial working environment with regular social events for team members and their families.
  • You’ll also be joining a bright and highly-motivated team working at the intersection of the most exciting areas of science and technology.

Job Description

We are seeking an ambitious and talented molecular biologist, who is familiar with oligonucleotide chemistries, to help us develop oligonucleotide therapies for rare diseases. This ideal candidate will lead the research and development of novel approaches to use oligonucleotides therapeutically and methods to characterize oligonucleotides and their effects in biological systems. They will have a flexible attitude to job roles and superlative organizational, interpersonal, and communication skills.

 

Requirements

  • PhD in the biological sciences or chemistry with at least 2 years of postgraduate experience, preferably in biotechnology or a pharmaceutical industry setting
  • Extensive experience with oligonucleotides and standard techniques in molecular and cell biology including, for example, DNA/RNA/Protein isolation and analysis, genetic manipulation of mammalian cells (e.g. CRISPR/Cas9), flow cytometry, etc.
  • Previous experience working with any / all of the following is desirable: collaborated with oligonucleotide CROs and cellular/animal models of mendelian disorders
  • Comfortable working with limited supervision in a fast-paced and rapidly growing work environment

How to Apply

To apply for this position, please click on the below link:

 

https://jobs.lever.co/deepgenomics/84558800-f4f5-…

About Our Organization

Deep Genomics is a Toronto-based startup company that is building an AI-powered discovery and development platform to significantly expand the universe of medicines available for genetically-defined diseases. Founded in 2015, Deep Genomics brings together a multidisciplinary team of world-leading experts in machine learning, genomics, chemistry, and biology. Together we are on a mission to rapidly discover and develop oligonucleotide drugs for the treatment of patients with severe disorders of the liver, central nervous system, and eye.

 

Career Blog headlines

The Pandemic and Women in STEM

The New York Times reports on how the COVID-19 pandemic may affect women in STEM.

Missing from the Top

A new report finds that women, especially women of color, are missing among the high-earners at research universities in the US, the Chronicle of Higher Education writes. 

Time Lost

Researcher-parents, especially mothers of small children, have lost research time during the COVID-19 pandemic, according to the Chronicle of Higher Education.

Time of Preprints

Inside Higher Ed reports that the preprint site medRxiv has taken off with the COVID-19 pandemic.